Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,110 | 37,958 | 38,751 | 42,124 | 19,913 |
| Receivables | 16,918 | 29,152 | 36,891 | 32,265 | 34,238 |
| Inventories | 10,976 | 14,391 | 13,659 | 24,153 | 22,139 |
| Other current assets | 1,343 | 3,382 | 4,722 | 3,082 | 2,740 |
| TOTAL | $65,547 | $84,883 | $94,023 | $101,624 | $81,521 |
| Non-Current Assets | |||||
| PPE Net | 25,894 | 30,620 | 31,587 | 33,121 | 34,144 |
| Investments And Advances | 0 | 191 | 191 | 191 | 191 |
| Intangibles | 44 | 228 | 236 | 244 | 228 |
| Other Non-Current Assets | 876 | 2,277 | 2,147 | 2,148 | 2,147 |
| TOTAL | $26,814 | $33,316 | $34,161 | $35,704 | $36,710 |
| Total Assets | $92,361 | $118,199 | $128,184 | $137,328 | $118,231 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,968 | 1,732 | 3,102 | 7,375 |
| Accounts payable and accrued liabilities | 2,991 | 5,976 | 6,628 | 2,646 | 5,549 |
| Accrued Expenses | 1,597 | 2,464 | 5,279 | 6,979 | 7,792 |
| Other current liabilities | N/A | 288 | 288 | 573 | N/A |
| TOTAL | $8,877 | $15,457 | $18,391 | $17,906 | $24,245 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 10,542 |
| Deferred Revenues | 1,321 | 1,700 | 1,499 | 2,057 | 1,003 |
| Other Non-Current Liabilities | 2 | 20 | 174 | 518 | 4,811 |
| TOTAL | $338 | $126 | $266 | $666 | $15,572 |
| Total Liabilities | $9,215 | $15,583 | $18,657 | $18,572 | $39,817 |
| Shareholders' Equity | |||||
| Common Shares | 190,550 | 188,603 | 188,609 | 186,434 | 138,508 |
| Retained earnings | -129,343 | -107,577 | -100,222 | -88,409 | -74,542 |
| Other shareholders' equity | 21,939 | 21,590 | 21,140 | 20,731 | 14,448 |
| TOTAL | $83,146 | $102,616 | $109,527 | $118,756 | $78,414 |
| Total Liabilities And Equity | $92,361 | $118,199 | $128,184 | $137,328 | $118,231 |